The recombinant congenic strains--a novel genetic tool applied to the study of colon tumor development in the mouse.
The development of tumors in mice is under multigenic control, but, in spite of considerable efforts, the identification of the genes involved has so far been unsuccessful, because of the insufficient resolution power of the available genetic tools. Therefore, a novel genetic tool, the RC (Recombinant Congenic) strains system, was designed. In this system, a series of RC strains is produced from two inbred strains, a "background" strain and a "donor" strain. Each RC strain contains a different small subset of genes from the donor strain and the majority of genes from the background strain. As a consequence, the individual genes of the donor strain which are involved in the genetic control of a multigenic trait, become separated into different RC strains, where they can be identified and studied individually. One of the RC strains series which we produced is made from the parental strains BALB/cHeA (background strain) and STS/A (donor strain). We describe the genetic composition of this BALB/cHeA-C-STS/A (CcS/Dem) series and show, using 45 genetic autosomal markers, that it does not deviate from the theoretical expectation. We studied the usefulness of the CcS/Dem RC strains for analysis of the genetics of colon tumor development. The two parental strains, BALB/cHeA and STS/A, are relatively resistant and highly susceptible, respectively, to the induction of colon tumors by 1,2-dimethylhydrazine (DMH). The individual RC strains differ widely in colon tumor development after DMH treatment; some are highly susceptible, while others are very resistant. This indicates that a limited number of genes with a major effect are responsible for the high susceptibility of the STS strain. Consequently, these genes can be mapped by further analysis of the susceptible RC strains. The differences between the RC strains were not limited to the number of tumors, but the RC strains differed also in size of the tumors and the relative susceptibility of the two sexes. Our data indicate that the number of tumors and the size of tumors are not controlled by the same genes. The genetics of these different aspects of colon tumorigenesis can also be studied by the RC strains. The DMH-treated mice of the parental strains and the RC strains also developed anal tumors and haemangiomas in varying numbers. The strain distribution pattern (SDP) of susceptibility for each of the three types of tumors induced by DMH is different, indicating that development of these tumors is under control of different, largely non-overlapping, sets of genes.(ABSTRACT TRUNCATED AT 400 WORDS)
Moen
C J
CJ
Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam.
van der Valk
M A
MA
Snoek
M
M
van Zutphen
B F
BF
von Deimling
O
O
Hart
A A
AA
Demant
P
P
D019813:1,2-Dimethylhydrazine; D000818:Animals; D014408:Biomarkers, Tumor; D015197:Carcinogenicity Tests; D003110:Colonic Neoplasms / Q000235:genetics*; D015342:DNA Probes; D004127:Dimethylhydrazines; D005260:Female; D020022:Genetic Predisposition to Disease; D007519:Isoantigens; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D012150:Polymorphism, Restriction Fragment Length; D011995:Recombination, Genetic; D012727:Sex Characteristics
D014408:Biomarkers, Tumor; D015342:DNA Probes; D004127:Dimethylhydrazines; D007519:Isoantigens; D019813:1,2-Dimethylhydrazine